Novel plasma biomarkers in arrhythmogenic cardiomyopathy: The role of ST2 and GDF-15 in predicting biventricular involvement

28 August 2020 (08:00 - 18:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Deniz Akdis

University Heart Center, Zurich (Switzerland)

34 More presentations in this session

Presentation thumbnail

Usefulness of late gadolinium enhancement cardiac magnetic resonance to predict appropriate therapies in implantable cardioverter defibrillator patients in primary prevention

Miss P. Sanchez Somonte (Girona, ES)

Abstract Slides

Presentation thumbnail

Incidence of sudden cardiac death after heart transplantation

Doctor G. Bonnet (Bordeaux, FR)

Abstract Slides

Presentation thumbnail

Idiopathic HFrEF. Is there room left for defibrillators?

Doctor F. Fernandes Gama (Carnaxide, PT)

Abstract Slides

Presentation thumbnail

Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy

Doctor N. Parashar (Delhi, IN)

Abstract Slides

Presentation thumbnail

Arrhythmogenic cardiomyopathy is characterized by apex-to-base heterogeneity of right ventricular myocardial contractility and stiffness: an imaging-based patient-specific modeling study

Mr N. van Osta (Maastricht, NL)

Abstract Slides

Access the full session

Session thumbnail

Ventricular Arrhythmias and Sudden Cardiac Death (SCD) ePosters

The Event

ESC Congress 2020

28 August 2020 08:00 CET

You may be interested in

Congress Session

Risk assessment and prevention of sudden cardiac death in cardiomyopathies

Congress Session

Gaps in risk stratification for patients with structural heart disease

Webinar

The role of cardiac magnetic resonance for patients with ventricular arrhythmias and the prevention of sudden cardiac death in light of the 2022 ESC Guidelines

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources